F. Martin‐Nizard

发表

Vasorelaxant and anti-platelet aggregation effects of aqueous Ocimum basilicum extract.

L. Boscá, H. Harnafi, M. Aziz, 2009, Journal of ethnopharmacology.

Phenolic profiles and antioxidative effects of hawthorn cell suspensions, fresh fruits, and medicinal dried parts

J. Hilbert, S. Grec, T. Hennebelle, 2009 .

Long-Term Risperidone Treatment Induces Visceral Adiposity Associated with Hepatic Steatosis in Mice: A Magnetic Resonance Approach

R. Bordet, P. Duriez, F. Auger, 2014, Schizophrenia research and treatment.

Modified low density lipoproteins activate human macrophages to secrete immunoreactive endothelin

J. Fruchart, P. Duriez, F. Martin-Nizard, 1991, FEBS letters.

Peroxisome Proliferator–activated Receptor Activators Inhibit Oxidized Low-density Lipoprotein–induced Endothelin-1 Secretion in Endothelial Cells

B. Staels, J. Fruchart, P. Delerive, 2002, Journal of cardiovascular pharmacology.

Natural phenylpropanoids protect endothelial cells against oxidized LDL-induced cytotoxicity.

J. Fruchart, P. Duriez, F. Bailleul, 2003, Planta medica.

Differential toxicities of air (mO‐LDL) or copper‐oxidized LDLs (Cu‐LDL) toward endothelial cells

J. Fruchart, P. Duriez, E. Teissier, 1999, Journal of biochemical and molecular toxicology.

Alpha-Tocopherol But Not Beta-Tocopherol Inhibits Thrombin-Induced PKC Activation and Endothelin Secretion in Endothelial Cells

J. Fruchart, P. Duriez, A. Boullier, 1998, Journal of cardiovascular risk.

Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway.

B. Staels, J. Fruchart, G. Chinetti, 1999, Circulation research.

Fenofibrate Inhibits Endothelin-1 Expression by Peroxisome Proliferator–Activated Receptor &agr;–Dependent and Independent Mechanisms in Human Endothelial Cells

G. Watts, B. Staels, F. Rodríguez-Pascual, 2013, Arteriosclerosis, thrombosis, and vascular biology.

The PPARα Activator Fenofibrate Slows Down the Progression of the Left Ventricular Dysfunction in Porcine Tachycardia-Induced Cardiomyopathy

D. Lacroix, B. Staels, G. Torpier, 2007, Journal of cardiovascular pharmacology.

Paullinia pinnata Extracts Rich in Polyphenols Promote Vascular Relaxation via Endothelium-dependent Mechanisms

R. Bordet, B. Staels, S. Şahpaz, 2006, Journal of cardiovascular pharmacology.

Analysis of phospholipid transfer during HDL binding to platelets using a fluorescent analog of phosphatidylcholine.

G. Torpier, J. Fruchart, P. Duthilleul, 1987, Thrombosis research.

Increased Susceptibility of Low-Density Lipoprotein to Ex Vivo Oxidation in Mice Transgenic for Human Apolipoprotein B Treated with 1 Melatonin-Related Compound Is Not Associated with Atherosclerosis Progression

R. Bordet, D. Lesieur, G. Torpier, 2005, Journal of cardiovascular pharmacology.

Pertussis toxin sensitive G-protein coupling of HDL receptor to phospholipase C in human platelets.

J. Fruchart, V. Clavey, H. Nazih, 1992, Thrombosis research.

Interactions of high-density lipoprotein 3 with brain capillary endothelial cells.

R. Cecchelli, S. Méresse, J. Fruchart, 1989, Biochimica et biophysica acta.

PON1, a new biomarker of cardiovascular disease, is low in patients with systemic vasculitis.

E. Hachulla, J. Fruchart, X. Kyndt, 2007, Seminars in arthritis and rheumatism.

A high concentration of melatonin inhibits in vitro LDL peroxidation but not oxidized LDL toxicity toward cultured endothelial cells.

D. Lesieur, J. Fruchart, S. Lestavel, 1998, Journal of cardiovascular pharmacology.

Oxidized High-Density Lipoproteins Modulate Endothelin Secretion by Adult Bovine Aortic Endothelial Cells

J. Fruchart, P. Duriez, A. Boullier, 1995, Journal of cardiovascular risk.

Oxidised LDL Modulates Endothelin Secretion by Adult Bovine Aortic Endothelial Cells

J. Fruchart, P. Duriez, A. Boullier, 1995 .

Low-density lipoprotein for delivery of an acrylophenone antineoplastic molecule into malignant cells.

D. Lesieur, G. Favre, J. Fruchart, 1992, Cancer research.

Antioxydant activity of β-carboline derivatives in the LDL oxidation model.

P. Chavatte, S. Dilly, S. Yous, 2011, European journal of medicinal chemistry.